| 241 |
Chronic lymphocytic leukemia with unusual cytoplasmic anomaliesChronic lymphocytic leukemia with unusual cytoplasmic anomalies
Nicolas AthanaseNicolas Athanase
KMSID: 1140056 Blood Res. 2019;54(4):241-241. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.241 |
|
| 242 |
Recurred breast cancer presenting with autoimmune hemolytic anemiaRecurred breast cancer presenting with autoimmune hemolytic anemia
Joowon ParkJoowon Park
KMSID: 1140057 Blood Res. 2019;54(4):242-242. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.242 |
|
| 243 |
Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive!Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive!
François Vergez, Laetitia Largeaud, Lucie Oberic, Jean-Baptiste RieuFrançois Vergez, Laetitia Largeaud, Lucie Oberic, Jean-Baptiste Rieu
KMSID: 1140058 Blood Res. 2019;54(4):243-243. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.243 |
|
| 244 |
Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphomaClinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma
Do-Young Kim, Moo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, Deok Hwan Yang, Sung-Nam Lim, Sung-Yong OhDo-Young Kim, Moo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, Deok Hwan Yang, Sung-Nam Lim, Sung-Yong Oh
KMSID: 1140059 Blood Res. 2019;54(4):244-252. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.244 |
|
| 253 |
Potential biomarkers and antagonists for fluoranthene-induced cellular toxicity of bone marrow derived mesenchymal stem cellsPotential biomarkers and antagonists for fluoranthene-induced cellular toxicity of bone marrow derived mesenchymal stem cells
Md Moinul Hoque, Young Eun Lee, Hye Ran Kim, Myung Geun ShinMd Moinul Hoque, Young Eun Lee, Hye Ran Kim, Myung Geun Shin
KMSID: 1140060 Blood Res. 2019;54(4):253-261. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.253 |
|
| 262 |
Evaluating the effect of donor anxiety levels and lifestyle characteristics on the activation of platelet concentratesEvaluating the effect of donor anxiety levels and lifestyle characteristics on the activation of platelet concentrates
Soner Yılmaz, İbrahim Eker, Elif Elçi, Aysel Pekel, Rıza Aytaç Çetinkaya, Aytekin Ünlü, Cengizhan Açıkel, İsmail Yaşar AvcıSoner Yılmaz, İbrahim Eker, Elif Elçi, Aysel Pekel, Rıza Aytaç Çetinkaya, Aytekin Ünlü, Cengizhan Açıkel, İsmail Yaşar Avcı
KMSID: 1140061 Blood Res. 2019;54(4):262-268. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.262 |
|
| 269 |
The increasing trend of blood donation in IranThe increasing trend of blood donation in Iran
Moslem Taheri Soodejani, Ali Akbar Haghdoost, Abbas Sedaghat, Mohammad Reza Baneshi, Farzaneh ZolalaMoslem Taheri Soodejani, Ali Akbar Haghdoost, Abbas Sedaghat, Mohammad Reza Baneshi, Farzaneh Zolala
KMSID: 1140062 Blood Res. 2019;54(4):269-273. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.269 |
|
| 274 |
Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCTClinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT
Neveen Lewis Mikhael, Manal ElsoradyNeveen Lewis Mikhael, Manal Elsorady
KMSID: 1140063 Blood Res. 2019;54(4):274-281. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.274 |
|
| 282 |
EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosisEBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
Shruti Prem, David Loach, Jeffrey Lipton, Rajat Kumar, Vikas GuptaShruti Prem, David Loach, Jeffrey Lipton, Rajat Kumar, Vikas Gupta
KMSID: 1140064 Blood Res. 2019;54(4):282-284. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.282 |
|
| 284 |
Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteriaRetrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria
Ik-Chan Song, Yoon-Seok Choi, Jong Wook Shin, Hee-Jung Song, Jei Kim, Deog-Yeon JoIk-Chan Song, Yoon-Seok Choi, Jong Wook Shin, Hee-Jung Song, Jei Kim, Deog-Yeon Jo
KMSID: 1140065 Blood Res. 2019;54(4):284-285. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.284 |
|
| 285 |
Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphomaBeta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma
Jaewon Hyung, Jung Yong Hong, Shin Kim, Jin Sook Ryu, Jooryung Huh, Cheolwon SuhJaewon Hyung, Jung Yong Hong, Shin Kim, Jin Sook Ryu, Jooryung Huh, Cheolwon Suh
KMSID: 1140066 Blood Res. 2019;54(4):285-288. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.285 |
|
| 288 |
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantationLong-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
Pasquale Niscola, Carmen Di Grazia, Carla Mazzone, Barbara Tolu, Paolo de Fabritiis, Emanuele AngelucciPasquale Niscola, Carmen Di Grazia, Carla Mazzone, Barbara Tolu, Paolo de Fabritiis, Emanuele Angelucci
KMSID: 1140067 Blood Res. 2019;54(4):288-290. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.288 |
|
| 290 |
Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioningDifferential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning
Mihong Choi, Dong-Yeop Shin, Ji Yun Lee, Inho Kim, Sung-Soo Yoon, Soo-Mee BangMihong Choi, Dong-Yeop Shin, Ji Yun Lee, Inho Kim, Sung-Soo Yoon, Soo-Mee Bang
KMSID: 1140068 Blood Res. 2019;54(4):290-295. Published online 2019 December 20 DOI: http://dx.doi.org/10.5045/br.2019.54.4.290 |
|
